Fintel reports that on March 4, 2025, Needham downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from Buy to ...

Fintel reports that on March 3, 2025, Needham initiated coverage of Amplitude (NasdaqCM:AMPL) with a Buy recommendation.

Needham lowered the firm’s price target on Praxis Precision (PRAX) to $85 from $150 and keeps a Buy rating on the shares. The firm is removing Ulixa sales from its model after the company disclosed ...

DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its price target reduced by Needham & Company LLC from $25.00 to $23.00 in a ...

Needham analyst Scott Berg initiated coverage of Amplitude (AMPL) with a Buy rating and $16 price target The firm views Amplitude shares to be ...

A tractor-trailer driver ran away from his truck after it crashed on an off-ramp in Massachusetts Thursday, police said.

Before Daryl Heller’s ATM network crashed down around him, the Lancaster County entrepreneur invested in a recreational ...

Needham raised the firm’s price target on Ambarella (AMBA) to $110 from $100 and keeps a Buy rating on the shares. The ...

As he steps down as IMDb CEO, Col Needham looks back at how an army of online friends created one of the most enduring spaces ...

After battling injuries all season, the junior forward returned to the lineup and lead the No. 12 Bishops in the next round ...

Needham-based real estate firm Waterstone Properties has purchased a Braintree retail property for $30 million.

Pliant Therapeutics (PLRX – Research Report) received a Hold rating and price target from Needham analyst Joseph Stringer today. The ...